BCC Research Publishes New Report on Global Market for Life Science Tools and Reagents
This technical market research report from BCC Research provides an overview of the global market for tools and reagents in the life sciences, genomics, and proteomics. The key objective is to present a comprehensive analysis and future direction of this market as an important tool for the identification of various types of proteins.
Wellesley, MA (PRWEB) January 29, 2014
According to a new technical market research report, Life Science Tools and Reagents: Global Markets, from BCC Research (http://www.bccresearch.com), the global market for life science tools and reagents was valued at nearly $48 billion in 2012 and was estimated at $51.4 billion for 2013. BCC Research projects the market to grow to $77.6 billion by 2018, and register a five-year compound annual growth rate of 8.6% from 2013 to 2018.
A wide range of technology platforms facilitate analysis at the gene, protein, or cellular level. The research led by universities and research labs in core areas such as genomics, proteomics and cellular or functional biology, has led to innovation of designs for the life sciences tools and reagents market. Indeed, the polymerase chain reaction (PCR), developed in 1983, established a foundation for today’s genomic research and has revolutionized basic and applicative science. Universities and research labs are continuously experimenting in core areas such as genomics, proteomics, cellular and functional biology, to provide innovation with the design of new medical devices and therapies. The reagents and research tools used in the life sciences are essential fragments of this routine laboratory research, involving the areas of research, bioscience, diagnosis and education.
Gene regulation in disease and development is impacted by epigenetic features such as DNA methylation, chromatin structure and noncoding RNAs (ncRNAs). These features contribute to a complex regulatory circuit that requires robust tools to study. The life sciences and analytical tools market is mostly driven by the increasing use of reagents in therapeutics, basic research and commercial applications. The demand for biotechnology reagents is mainly dependent on the growth of the biotechnology instrumentation market. Continual product developments in various industries, such as pharmaceutical/ biopharmaceutical, agri-biotech, and food and beverages, are expected to facilitate the market’s growth in the next five years.
This technical market research report from BCC Research provides an overview of the global market for tools and reagents in the life sciences, genomics, and proteomics. The key objective is to present a comprehensive analysis and future direction of this market as an important tool for the identification of various types of proteins. To that end, this report explores present and future strategies within the tools and reagent market in the life sciences, which comprise several different segments, each offering different types of products and services. This report discusses in detail the following segments: molecular biology tools and reagents (DNA, RNA, and genomic-related products); proteomics-related products and services (protein expression, purification and identification market); recombinant proteins market and in vitro assay development; antibodies as a research tool; cell biology reagents and assay development; laboratory animal markets; imaging techniques and suppliers; bioinformatics tools; epigenetic research; and stem cells. In addition, this report discusses the growth of the market, as well as its setbacks and needs. Revenues are broken down by region. Sales figures are estimated for the five-year period from 2013 through 2018.
This report is intended for life sciences manufacturers and users, as well as business development professionals, entrepreneurs, and other investors who need to fully understand and properly evaluate each segment of the market for tools and reagents in the life sciences, genomics, and proteomics.
For the original version on PRWeb visit: http://www.prweb.com/releases/2014/01/prweb11533811.htm